Developer docs
API playgroundTry for free, no card

Search company profiles

DNAnexus

Full company profile

uuid00002e7

Namestring
DNAnexus
Legal namestring
DNAnexus, Inc.
Websiteurl
dnanexus.com
Company typeenum
Private
Founded yearint
2009
Descriptiontext

DNAnexus is a private, U.S.-based (San Francisco) cloud-software company founded in 2009 that operates the Precision Health Data Cloud, an enterprise platform for managing, analyzing, and collaborating on multiomics and clinical data across pharmaceutical and biotech companies, clinical diagnostics labs, academic medical centers, biobanks and population health programs, commercial real-world data businesses, and regulatory agencies such as the FDA. The platform is hosted on AWS and Microsoft Azure, encrypts sequence data with AES-256, and is certified or aligned to ISO 27001, NIST 800, HIPAA, GDPR, GxP/ICH, CAP/CLIA, FedRAMP, and 21 CFR Parts 11 and 820; it supports workflow orchestration across Nextflow, WDL, and Docker, embedded JupyterLab notebooks backed by Spark clusters (with R, SQL, TensorFlow, and PyTorch), a population-scale cohort browser used for the 500,000-participant UK Biobank dataset, and white-label Trusted Research Environments (including the UK Biobank RAP, Our Future Health TRE, and FDA precisionFDA).

The company's commercial offering is anchored by the Precision Health Data Cloud SaaS subscription, supplemented by Professional Services (implementation, GxP readiness, pipeline migration, AI/ML deployment), Managed Services (ongoing platform administration and bioinformatics), and usage-based cloud compute and storage on AWS and Azure. Distribution combines a high-touch enterprise field-sales motion ('Request a Demo', 'Schedule a Scientific Consultation') with multi-tier channel partnerships — the three major hyperscalers (AWS, Microsoft, Oracle), services and consulting partners (Accenture, Zifo, Epista, DataXight), technology partners (NVIDIA, Panomics, Fabric Genomics, Intelliseq, LORENZ), instrument partners (PacBio, Element Biosciences), and biobank/data partners (UK Biobank, Our Future Health, Ovation, TMA Precision Health). In March 2022, DNAnexus closed a $200 million funding round led by Blackstone Growth to fund global expansion and AI/ML integration; the company has since productized AI through the 2026 Innovation Hub (Omics Data Agent, AutoML Assistant, Omics Data Catalog) and packaged Solutions Packages for pharma and diagnostics, while expanding into new disease areas (multiple sclerosis, ALS, muscular dystrophy) and the U.S./European regulatory collaboration market through Trusted Regulatory Spaces and Project PRISM.

Short descriptiontext

DNAnexus provides the Precision Health Data Cloud, an enterprise SaaS platform for managing, analyzing, and collaborating on multiomics and clinical data, serving pharmaceutical, biotech, diagnostics, academic medical centers, biobanks, and regulatory customers globally.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
251–500
akta.pro rankint
HeadquartersMountain View, United States
HQ citystring
Mountain View
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices5 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
precision health cloud, multiomics data platform, biomedical data analytics, clinical genomics software, trusted research environment
Industry2 codes
PRIMARYHLAGANAI
Bioinformatics, Multi-Omics Data Analysis & Interpretation Services
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Specialty Lab Services (Genomics/Proteomics/Cellomics)
SECONDARYHLAGAJAD
Bioinformatics & Multi-omics Analysis Software
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Life Science Software & Informatics (LIMS/ELN/Bioinformatics)
NAICS code1 code
  • Computer Systems Design and Related Services54151
SIC code1 code
  • Services-Computer Programming, Data Processing, Etc.7370
Product category
Cloud-based biomedical data analytics platform (Precision Health Data Cloud)
GTM motion4 records

Each record includes

Type, Description, Source

Revenue model5 records
1Platform Subscription (Precision Health Data Cloud SaaS)
TypeSubscription Recurring
Description

Recurring subscription revenue from enterprise customers (pharma, biotech, diagnostics, medical centers, biobanks, regulatory) accessing the Precision Health Data Cloud SaaS platform hosted on AWS and Azure with role-based access, GxP-compliance, and analytics tooling.

dnanexus.com
2Professional Services
TypeProfessional Services
Description

Implementation, custom application development, pipeline migration/optimization, GxP readiness support, bioinformatics expertise, multiomics insight generation, and AI/ML deployment services — sold alongside platform subscriptions.

dnanexus.com
3Managed Services
TypeManaged Services
Description

Ongoing post-go-live management of customer DNAnexus systems, including platform configuration, administration, bioinformatics pipeline development, structural variant analysis, and multiomics insights generation.

dnanexus.com
4Usage-Based Cloud Compute & Storage
TypeUsage Based
Description

Consumption-based revenue tied to on-demand compute and storage services on AWS and Microsoft Azure, with role-based user management and spend/usage visibility features for customers.

dnanexus.com
5Data Enablement / B2B Data Sharing
TypeData Monetisation
Description

Revenue from data providers and real-world data businesses using DNAnexus as a Trusted Research Environment to package, dispense, and monetize clinico-multiomic datasets to commercial clients.

dnanexus.com
Marketing channels11 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels6 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Technology or R&D, Infrastructure, Personnel, Marketing or Sales, Operations
Pricing details1 tier
1Enterprise platform contract — quote-based, multi-year
ModelHybridBilling cadenceMulti-year contract
Notes

Custom enterprise pricing tied to platform access, compute, storage, and seats; not publicly listed. ROI study cites 395% return and 50% faster pipeline development.

dnanexus.com
GTM typeB2B
B2B
Offering typeSoftware
Software
Brand1 of 2 records shown
1Precision Health Data Cloud
Description

The DNAnexus enterprise orchestration platform for precision health, marketed as 'The Precision Health Data Cloud' and serving as the umbrella product offering.

dnanexus.com
+1 more record
Core offering1 text field

DNAnexus develops and operates the Precision Health Data Cloud, a SaaS platform hosted on AWS and Microsoft Azure that lets pharmaceutical, biotech, clinical diagnostics, biobank, and academic medical center customers store, analyze, and collaborate on multimodal omics and clinical data. The platform bundles bioinformatics pipelines, AI/ML tooling, a population-scale cohort browser, embedded JupyterLab with Spark, and compliance certifications (GxP, FedRAMP, HIPAA, GDPR, ISO 27001, CAP/CLIA), with attached Professional Services and Managed Services for implementation, GxP readiness, and ongoing operations.

Differentiator
Functional benefit
Problem solved
Product overview1 text field

DNAnexus offers the Precision Health Data Cloud as a unified enterprise platform with modular add-ons and packaged solutions. At its core is the DNAnexus Platform for managing, analyzing, and collaborating on multiomics and clinical data, complemented by the Trusted Regulatory Spaces (TRS) module for regulatory workflows. The Innovation Hub adds specialized AI-powered modules including the Omics Data Agent (GenAI virtual assistant), AutoML Assistant (conversational copilot), and Omics Data Catalog. Bundled Solutions Packages include the Omics Accelerator, Production Scaler, Next Gen Therapeutics Accelerator, Pre-Built Analysis Accelerators, and Molecular Testing Engine. Co-developed platforms include the UK Biobank Research Analysis Platform (RAP), EpiCypher CUTANA Cloud (powered by DNAnexus), City of Hope's POSEIDON precision oncology platform, and the FDA's precisionFDA Collaborative Omics Environment. Industry solutions span Pharmaceutical & Biotech, Academic Medical Centers, Clinical Diagnostics, Commercial Data Businesses, Biobanks & Population Programs, and Regulatory Solutions. The offering is supported by Professional Services, Managed Services, Solution Acceleration, and Training and Support.

Product and service12 records
1DNAnexus Precision Health Data Cloud Platform
CategoryCore platform (cloud SaaS)
2DNAnexus Trusted Regulatory Spaces (TRS)
CategoryRegulatory collaboration solution
3Omics Accelerator
CategorySolutions package (Innovation Hub)
4Production Scaler
CategorySolutions package (Innovation Hub)
5Next Gen Therapeutics Accelerator
CategorySolutions package (Innovation Hub)
6Pre-Built Analysis Accelerators
CategorySolutions package (Innovation Hub)
7Molecular Testing Engine
CategorySolutions package (Innovation Hub)
8Omics Data Agent
CategoryInnovation Hub AI product
9AutoML Assistant
CategoryInnovation Hub AI product
10Omics Data Catalog
CategoryInnovation Hub data management product
11DNAnexus Professional Services
CategoryProfessional services
12DNAnexus Managed Services
CategoryManaged services
Scale indicator12 records

Each record includes

Type, Value, Description, Source

Partnership26 partners
Strategic tierCore Technology PartnerTypeTechnology or IntegrationAnnounced on2024-01-01
Description

Intelliseq (Poland-based) and DNAnexus have partnered to simplify and accelerate variant interpretation and clinical reporting. The integrated one-click solution streamlines NGS data analysis and helps scientists generate insights into somatic cancers, hereditary diseases, and other precision medicine applications. Announced in January 2024.

2U.S. Food and Drug Administration (FDA)
Strategic tierFlagship Strategic PartnerTypeStrategic or Co-development PartnerAnnounced on2019-12-01
Description

FDA selected DNAnexus to power the precisionFDA Collaborative Omics Environment in the Cloud under a five-year, $20 million contract awarded in December 2019. The partnership enables FDA to enhance precisionFDA capabilities for sponsor-reviewer interaction, add support for multi-omics, and provide a library of analytical, statistical, and machine learning applications.

dnanexus.com
Strategic tierFlagship Cloud PartnerTypeTechnology or Integration
Description

DNAnexus teamed up with Oracle to advance precision health by connecting respective ecosystems, making the DNAnexus platform seamlessly available to global Oracle Cloud Infrastructure, Oracle Health, and Oracle Database customers. Per 2026 industry coverage, DNAnexus and Oracle Health collaborated in September 2025 to link genomic data to electronic health records.

Strategic tierFlagship Cloud PartnerTypeTechnology or Integration
Description

AWS is a strategic Technology Alliance partner of DNAnexus. Together they provide joint customers with the ability to accelerate research, foster collaboration, and deliver better outcomes. DNAnexus stores customer sequence data and account information on AWS cloud servers using AES-256 encryption.

Strategic tierFlagship Cloud PartnerTypeTechnology or Integration
Description

Microsoft and DNAnexus empower organizations to re-envision how they bring together people, data, and processes to better engage patients and optimize clinical and operational effectiveness. DNAnexus stores customer sequence data and account information on Microsoft Azure cloud servers using AES-256 encryption.

Strategic tierCore Technology PartnerTypeTechnology or Integration
Description

Panomics brings advanced additional multiomics analysis to DNAnexus, with biologist-friendly tools for transcriptomics and proteomics, interactive data exploration, and capabilities like gene co-perturbation and similarity search. The combination helps life sciences organizations accelerate biomarker discovery, drug repurposing, and precision medicine research.

Strategic tierCore Technology PartnerTypeTechnology or Integration
Description

NVIDIA partners with DNAnexus to accelerate time to value for scientific research. DNAnexus makes it easy to run NVIDIA Parabricks pipelines by providing an out-of-the-box solution.

Strategic tierCore Technology PartnerTypeTechnology or Integration
Description

Fabric Genomics and DNAnexus have partnered to provide a push-button solution to interpret genomic sequences, detect clinically meaningful variants, and generate comprehensive patient reports. The workflow reduces overall analysis costs and significantly improves turnaround times from days to hours for clinical rare genetic disorders and oncology diagnostics (announcement Nov 2023).

Strategic tierCore Technology PartnerTypeTechnology or Integration
Description

Lorenz Life Sciences and DNAnexus have partnered to offer Trusted Regulatory Spaces — secure, cloud-native environments that improve the submission validation process and ease of sponsor-reviewer communication for human drug and biologics applications to health authorities. The companies have joined industry leaders and FDA on Project PRISM to advance solutions for submission, review, and communication.

Strategic tierCore Strategic PartnerTypeStrategic or Co-development Partner
Description

DNAnexus expanded its relationship with Veeva to advance global regulatory collaboration. The companies come together to connect sponsors, agencies, and standards development organizations on a regulatory collaboration cloud.

Strategic tierCore Services PartnerTypeImplementation/ SI/ Consulting Partner
Description

DataXight is a full-service professional services organization that brings expertise across bioinformatics, artificial intelligence, large-scale data platforms, and product innovation. They offer end-to-end services including data services and strategy, advanced analytics workflows, and scientific decision support.

Strategic tierCore Services PartnerTypeImplementation/ SI/ Consulting Partner
Description

Zifo is a global specialist scientific and process informatics service provider working across research, development, manufacturing and clinical domains with expertise in over 90 partner technologies and platforms.

Strategic tierCore Services PartnerTypeImplementation/ SI/ Consulting Partner
Description

Epista Life Science provides leading consulting services across the product development lifecycle for system implementations and advisory support. With strong expertise in Regulatory, Clinical, and Quality domains, Epista is the preferred partner for Trusted Regulatory Space deployment.

Strategic tierCore Services PartnerTypeImplementation/ SI/ Consulting Partner
Description

Accenture is a leading global professional services company that helps the world's leading businesses, governments, and other organizations build their digital core, optimize their operations, accelerate revenue growth, and enhance citizen services — creating tangible value at speed and scale.

Strategic tierFlagship Data/Biobank PartnerTypeStrategic or Co-development Partner
Description

DNAnexus has been selected as the platform provider of the Trusted Research Environment for Our Future Health, the United Kingdom's largest health research program — a collaboration between the public, private, and charity sectors aimed at preventing, detecting, and treating disease.

Strategic tierFlagship Data/Biobank PartnerTypeStrategic or Co-development Partner
Description

The UK Biobank Research Analysis Platform (RAP), enabled by DNAnexus, exponentially increases the scale and accessibility of the world's largest and most comprehensive biomedical database for researchers around the world to advance understanding of human disease. UK Biobank contains in-depth genetic and health information from 500,000 UK participants.

Strategic tierCore Data PartnerTypeStrategic or Co-development Partner
Description

Ovation is a clinicogenomic data company committed to unlocking the potential of human genomic data to accelerate precision medicine. DNAnexus and Ovation teamed up to unlock large-scale precision health datasets to accelerate drug discovery.

Strategic tierCore Data PartnerTypeStrategic or Co-development Partner
Description

TMA Precision Health and DNAnexus have partnered to advance basic and translational research for patients who have a rare disease. Qualified researchers can use the DNAnexus Precision Health Data Cloud to access and explore TMA's high-quality whole genome sequencing data and associated longitudinal medical records.

Strategic tierCore Instrument PartnerTypeOEM/ Whitelabel/ Licensing Partner
Description

PacBio is a premier life science technology company designing, developing, and manufacturing advanced sequencing solutions. DNAnexus and PacBio have collaborated to accelerate PacBio workflows on DNAnexus with Sentieon, with joint webinar content.

Strategic tierCore Instrument PartnerTypeOEM/ Whitelabel/ Licensing Partner
Description

Element Biosciences is developing disruptive DNA sequencing and other omics technology for research and diagnostic markets. DNAnexus and Element Biosciences have partnered to allow customers to stream data from Element's AVITI System directly to their DNAnexus account, combining unmatched AVITI sequencing performance with the DNAnexus multi-omic analysis platform.

Strategic tierCore Technology PartnerTypeTechnology or Integration
Description

EpiCypher launched CUTANA Cloud, a powerful epigenomic data analysis platform powered by DNAnexus that accelerates data analysis for leading chromatin mapping technologies including CUT&RUN and CUT&Tag. The platform was announced in November 2025.

Strategic tierCore Technology PartnerTypeTechnology or Integration
Description

DNAnexus and BigOmics partner to provide seamless omics analysis through a joint solution brief for biotech and pharma customers.

23Boehringer Ingelheim
Strategic tierFlagship Strategic PartnerTypeStrategic or Co-development Partner
Description

Boehringer Ingelheim and DNAnexus are 2025 Prix Galien USA finalists for Best Digital Health Solution. Vada Perkins, VP & Global Head of Regulatory Intelligence & Policy at Boehringer Ingelheim, collaborates with DNAnexus on Trusted Regulatory Spaces and Cloud Transformation webinars.

dnanexus.com
24Accelerated Cure Project for MS
Strategic tierStrategic PartnerTypeStrategic or Co-development Partner
Description

Accelerated Cure Project for MS (ACP) launched the ACP Data Challenge Pilot, a new initiative inviting researchers to interrogate ACP's longitudinal and multi-omic MS data in a single secure DNAnexus-powered environment (announced June 2026).

dnanexus.com
25Longitude Prize on ALS
Strategic tierStrategic PartnerTypeStrategic or Co-development Partner
Description

Longitude Prize on ALS Discovery Award selections include 20 multidisciplinary teams using cutting-edge AI on DNAnexus-powered Prize datasets. Discovery Awardees were awarded £100,000 each plus access to the Prize datasets and a technical support package to drive computational work.

dnanexus.com
Strategic tierFlagship Strategic PartnerTypeStrategic or Co-development Partner
Description

ARPA-H pioneers adaptive cancer treatment, leveraging DNAnexus technology. Featured as one of the trusted biomedical leaders on the DNAnexus homepage.

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight7 records

Each record includes

Type, Description

Peers10 records
1AWS HealthOmics
TypeBroad incumbent
Description

AWS HealthOmics provides managed genomics and multiomics storage and workflow services natively on AWS — the same cloud DNAnexus runs on — and represents both a partner and a potential disintermediator for less-regulated workloads.

TypeBroad incumbent
Description

Illumina, the dominant sequencing instrument vendor, offers Connected Analytics and DRAGEN-based cloud pipelines that overlap DNAnexus's NGS secondary analysis and multiomics workflows as part of a broader sequencing ecosystem.

TypeEmerging player
Description

Owkin applies federated AI to clinical and omics data for biopharma and academic medical centers, intersecting DNAnexus's territory in AI-enabled translational research and multimodal data collaboration.

TypeDirect peer
Description

BC Platforms provides a genomics and real-world data platform used by biobanks, pharma, and healthcare systems, with a comparable Trusted Research Environment and B2B data monetization model.

TypeDirect peer
Description

Lifebit builds a cloud-based biomedical data platform (Lifebit CloudOS) for federated genomics and multi-omics analysis, directly competing with DNAnexus Precision Health Data Cloud for pharma, biobank, and translational research customers.

TypeDirect peer
Description

Velsera operates the Seven Bridges Platform for biomedical data analysis and clinical interpretation, overlapping DNAnexus in NGS analysis, multiomics workflows, and pharma/biopharma translational research customers.

TypeDirect peer
Description

SOPHiA GENETICS offers the SOPHiA DDM Platform for genomics data analysis and clinical decision support, competing directly in clinical diagnostics, NGS interpretation, and hospital lab workflows.

8Microsoft Azure Health Data Services
TypeBroad incumbent
Description

Microsoft Azure Health Data Services offers cloud-based healthcare and life sciences data services natively on Azure, competing and partnering with DNAnexus across pharma R&D and clinical genomics workloads.

TypeBroad incumbent
Description

Databricks' Healthcare & Life Sciences Lakehouse competes with DNAnexus for pharma R&D data unification, ML on multiomics, and collaborative analysis — at a broader, less biomedical-specialized level.

TypeEmerging player
Description

Form Bio provides a cloud-based computational platform for genomics and synthetic biology data, with partial overlap to DNAnexus in NGS pipelines, multiomics analysis, and pharma R&D tooling.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat6 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers30 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment7 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile6 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
Yes

Docs URL, Description

Integration8 records

Each record includes

Title, Type, Description, Source

AI capability10 records

Each record includes

Type, Description, Source

AI maturity
App detail

Has app

Feature8 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles14 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
Compliance9 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds9 records

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors18 records

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

DNAnexus

Cloud-based biomedical data analytics platform (Precision Health Data Cloud)dnanexus.com

DNAnexus provides the Precision Health Data Cloud, an enterprise SaaS platform for managing, analyzing, and collaborating on multiomics and clinical data, serving pharmaceutical, biotech, diagnostics, academic medical centers, biobanks, and regulatory customers globally.

What DNAnexus does

DNAnexus is a private, U.S.-based (San Francisco) cloud-software company founded in 2009 that operates the Precision Health Data Cloud, an enterprise platform for managing, analyzing, and collaborating on multiomics and clinical data across pharmaceutical and biotech companies, clinical diagnostics labs, academic medical centers, biobanks and population health programs, commercial real-world data businesses, and regulatory agencies such as the FDA. The platform is hosted on AWS and Microsoft Azure, encrypts sequence data with AES-256, and is certified or aligned to ISO 27001, NIST 800, HIPAA, GDPR, GxP/ICH, CAP/CLIA, FedRAMP, and 21 CFR Parts 11 and 820; it supports workflow orchestration across Nextflow, WDL, and Docker, embedded JupyterLab notebooks backed by Spark clusters (with R, SQL, TensorFlow, and PyTorch), a population-scale cohort browser used for the 500,000-participant UK Biobank dataset, and white-label Trusted Research Environments (including the UK Biobank RAP, Our Future Health TRE, and FDA precisionFDA).

The company's commercial offering is anchored by the Precision Health Data Cloud SaaS subscription, supplemented by Professional Services (implementation, GxP readiness, pipeline migration, AI/ML deployment), Managed Services (ongoing platform administration and bioinformatics), and usage-based cloud compute and storage on AWS and Azure. Distribution combines a high-touch enterprise field-sales motion ('Request a Demo', 'Schedule a Scientific Consultation') with multi-tier channel partnerships — the three major hyperscalers (AWS, Microsoft, Oracle), services and consulting partners (Accenture, Zifo, Epista, DataXight), technology partners (NVIDIA, Panomics, Fabric Genomics, Intelliseq, LORENZ), instrument partners (PacBio, Element Biosciences), and biobank/data partners (UK Biobank, Our Future Health, Ovation, TMA Precision Health). In March 2022, DNAnexus closed a $200 million funding round led by Blackstone Growth to fund global expansion and AI/ML integration; the company has since productized AI through the 2026 Innovation Hub (Omics Data Agent, AutoML Assistant, Omics Data Catalog) and packaged Solutions Packages for pharma and diagnostics, while expanding into new disease areas (multiple sclerosis, ALS, muscular dystrophy) and the U.S./European regulatory collaboration market through Trusted Regulatory Spaces and Project PRISM.

DNAnexus firmographics

Firmographics
Name
DNAnexus
Legal name
DNAnexus, Inc.
Website
https://dnanexus.com
Company type
Private
Founded year
2009
Operating status
Operating
Headcount range
251–500 employees
Short description
DNAnexus provides the Precision Health Data Cloud, an enterprise SaaS platform for managing, analyzing, and collaborating on multiomics and clinical data, serving pharmaceutical, biotech, diagnostics, academic medical centers, biobanks, and regulatory customers globally.
Ownership category
akta.pro rank

DNAnexus industry classification

Industry
Product category
Cloud-based biomedical data analytics platform (Precision Health Data Cloud)
NAICS
Computer Systems Design and Related Services (54151)
SIC
Services-Computer Programming, Data Processing, Etc. (7370)
akta.pro industry
PRIMARYHLAGANAI
Bioinformatics, Multi-Omics Data Analysis & Interpretation Services
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Specialty Lab Services (Genomics/Proteomics/Cellomics)
SECONDARYHLAGAJAD
Bioinformatics & Multi-omics Analysis Software
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Life Science Software & Informatics (LIMS/ELN/Bioinformatics)

Keywords

  • Precision health cloud
  • Multiomics data platform
  • Biomedical data analytics
  • Clinical genomics software
  • Trusted research environment

Where DNAnexus is headquartered

Location

Headquarters

HQ city
Mountain View
HQ country
United States
HQ region
North America

Offices5 records

Markets served

DNAnexus business model

Business model
GTM type
B2B
Offering type
Software
Cost components
Technology or R&D, Infrastructure, Personnel, Marketing or Sales, Operations

Revenue model

  1. Platform Subscription (Precision Health Data Cloud SaaS): Recurring subscription revenue from enterprise customers (pharma, biotech, diagnostics, medical centers, biobanks, regulatory) accessing the Precision Health Data Cloud SaaS platform hosted on AWS and Azure with role-based access, GxP-compliance, and analytics tooling.
  2. Professional Services: Implementation, custom application development, pipeline migration/optimization, GxP readiness support, bioinformatics expertise, multiomics insight generation, and AI/ML deployment services — sold alongside platform subscriptions.
  3. Managed Services: Ongoing post-go-live management of customer DNAnexus systems, including platform configuration, administration, bioinformatics pipeline development, structural variant analysis, and multiomics insights generation.
  4. Usage-Based Cloud Compute & Storage: Consumption-based revenue tied to on-demand compute and storage services on AWS and Microsoft Azure, with role-based user management and spend/usage visibility features for customers.
  5. Data Enablement / B2B Data Sharing: Revenue from data providers and real-world data businesses using DNAnexus as a Trusted Research Environment to package, dispense, and monetize clinico-multiomic datasets to commercial clients.

Pricing tiers

ModelBillingPrice
HybridMulti-year contractEnterprise platform contract — quote-based, multi-year

Go-to-market motion4 records

Distribution channels6 records

Marketing channels11 records

DNAnexus product offering

Product offering

Core offering

DNAnexus develops and operates the Precision Health Data Cloud, a SaaS platform hosted on AWS and Microsoft Azure that lets pharmaceutical, biotech, clinical diagnostics, biobank, and academic medical center customers store, analyze, and collaborate on multimodal omics and clinical data. The platform bundles bioinformatics pipelines, AI/ML tooling, a population-scale cohort browser, embedded JupyterLab with Spark, and compliance certifications (GxP, FedRAMP, HIPAA, GDPR, ISO 27001, CAP/CLIA), with attached Professional Services and Managed Services for implementation, GxP readiness, and ongoing operations.

Product overview

DNAnexus offers the Precision Health Data Cloud as a unified enterprise platform with modular add-ons and packaged solutions. At its core is the DNAnexus Platform for managing, analyzing, and collaborating on multiomics and clinical data, complemented by the Trusted Regulatory Spaces (TRS) module for regulatory workflows. The Innovation Hub adds specialized AI-powered modules including the Omics Data Agent (GenAI virtual assistant), AutoML Assistant (conversational copilot), and Omics Data Catalog. Bundled Solutions Packages include the Omics Accelerator, Production Scaler, Next Gen Therapeutics Accelerator, Pre-Built Analysis Accelerators, and Molecular Testing Engine. Co-developed platforms include the UK Biobank Research Analysis Platform (RAP), EpiCypher CUTANA Cloud (powered by DNAnexus), City of Hope's POSEIDON precision oncology platform, and the FDA's precisionFDA Collaborative Omics Environment. Industry solutions span Pharmaceutical & Biotech, Academic Medical Centers, Clinical Diagnostics, Commercial Data Businesses, Biobanks & Population Programs, and Regulatory Solutions. The offering is supported by Professional Services, Managed Services, Solution Acceleration, and Training and Support.

Differentiator

Problem solved

Functional benefit

Brands

  • Precision Health Data Cloud: The DNAnexus enterprise orchestration platform for precision health, marketed as 'The Precision Health Data Cloud' and serving as the umbrella product offering.
  • DNAnexus Innovation Hub

Products and services

  • DNAnexus Precision Health Data Cloud Platform
  • DNAnexus Trusted Regulatory Spaces (TRS)
  • Omics Accelerator
  • Production Scaler
  • Next Gen Therapeutics Accelerator
  • Pre-Built Analysis Accelerators
  • Molecular Testing Engine
  • Omics Data Agent
  • AutoML Assistant
  • Omics Data Catalog
  • DNAnexus Professional Services
  • DNAnexus Managed Services

Companies that use DNAnexus

Customer profile

Named customers30 records

Segments7 records

Ideal customer profiles6 records

DNAnexus technology and API

Technology

Technology focussed Yes

API detail

Has API
Yes
API docs
API detail

Core technology

AI maturity

App detail

Integration8 records

AI capability10 records

Feature8 records

DNAnexus partnerships and signals

Strategic signal

Partnerships

26 partnerships are on record, tiered core technology partner, flagship strategic partner, flagship cloud partner, core strategic partner, core services partner, flagship data/biobank partner, core data partner, core instrument partner and strategic partner.

  • Intelliseqcore technology partnerTechnology or Integration · 1 January 2024Intelliseq (Poland-based) and DNAnexus have partnered to simplify and accelerate variant interpretation and clinical reporting. The integrated one-click solution streamlines NGS data analysis and helps scientists generate insights into somatic cancers, hereditary diseases, and other precision medicine applications. Announced in January 2024.
  • U.S. Food and Drug Administration (FDA)flagship strategic partnerStrategic or Co-development Partner · 1 December 2019FDA selected DNAnexus to power the precisionFDA Collaborative Omics Environment in the Cloud under a five-year, $20 million contract awarded in December 2019. The partnership enables FDA to enhance precisionFDA capabilities for sponsor-reviewer interaction, add support for multi-omics, and provide a library of analytical, statistical, and machine learning applications.
  • Oracleflagship cloud partnerTechnology or IntegrationDNAnexus teamed up with Oracle to advance precision health by connecting respective ecosystems, making the DNAnexus platform seamlessly available to global Oracle Cloud Infrastructure, Oracle Health, and Oracle Database customers. Per 2026 industry coverage, DNAnexus and Oracle Health collaborated in September 2025 to link genomic data to electronic health records.
  • Amazon Web Services (AWS)flagship cloud partnerTechnology or IntegrationAWS is a strategic Technology Alliance partner of DNAnexus. Together they provide joint customers with the ability to accelerate research, foster collaboration, and deliver better outcomes. DNAnexus stores customer sequence data and account information on AWS cloud servers using AES-256 encryption.
  • Microsoftflagship cloud partnerTechnology or IntegrationMicrosoft and DNAnexus empower organizations to re-envision how they bring together people, data, and processes to better engage patients and optimize clinical and operational effectiveness. DNAnexus stores customer sequence data and account information on Microsoft Azure cloud servers using AES-256 encryption.
  • Panomicscore technology partnerTechnology or IntegrationPanomics brings advanced additional multiomics analysis to DNAnexus, with biologist-friendly tools for transcriptomics and proteomics, interactive data exploration, and capabilities like gene co-perturbation and similarity search. The combination helps life sciences organizations accelerate biomarker discovery, drug repurposing, and precision medicine research.
  • NVIDIAcore technology partnerTechnology or IntegrationNVIDIA partners with DNAnexus to accelerate time to value for scientific research. DNAnexus makes it easy to run NVIDIA Parabricks pipelines by providing an out-of-the-box solution.
  • Fabric Genomicscore technology partnerTechnology or IntegrationFabric Genomics and DNAnexus have partnered to provide a push-button solution to interpret genomic sequences, detect clinically meaningful variants, and generate comprehensive patient reports. The workflow reduces overall analysis costs and significantly improves turnaround times from days to hours for clinical rare genetic disorders and oncology diagnostics (announcement Nov 2023).
  • Lorenz Life Sciences (LORENZ)core technology partnerTechnology or IntegrationLorenz Life Sciences and DNAnexus have partnered to offer Trusted Regulatory Spaces — secure, cloud-native environments that improve the submission validation process and ease of sponsor-reviewer communication for human drug and biologics applications to health authorities. The companies have joined industry leaders and FDA on Project PRISM to advance solutions for submission, review, and communication.
  • Veeva Systemscore strategic partnerStrategic or Co-development PartnerDNAnexus expanded its relationship with Veeva to advance global regulatory collaboration. The companies come together to connect sponsors, agencies, and standards development organizations on a regulatory collaboration cloud.
  • DataXightcore services partnerImplementation/ SI/ Consulting PartnerDataXight is a full-service professional services organization that brings expertise across bioinformatics, artificial intelligence, large-scale data platforms, and product innovation. They offer end-to-end services including data services and strategy, advanced analytics workflows, and scientific decision support.
  • Zifo Technologiescore services partnerImplementation/ SI/ Consulting PartnerZifo is a global specialist scientific and process informatics service provider working across research, development, manufacturing and clinical domains with expertise in over 90 partner technologies and platforms.
  • Epista Life Sciencecore services partnerImplementation/ SI/ Consulting PartnerEpista Life Science provides leading consulting services across the product development lifecycle for system implementations and advisory support. With strong expertise in Regulatory, Clinical, and Quality domains, Epista is the preferred partner for Trusted Regulatory Space deployment.
  • Accenturecore services partnerImplementation/ SI/ Consulting PartnerAccenture is a leading global professional services company that helps the world's leading businesses, governments, and other organizations build their digital core, optimize their operations, accelerate revenue growth, and enhance citizen services — creating tangible value at speed and scale.
  • Our Future Healthflagship data/biobank partnerStrategic or Co-development PartnerDNAnexus has been selected as the platform provider of the Trusted Research Environment for Our Future Health, the United Kingdom's largest health research program — a collaboration between the public, private, and charity sectors aimed at preventing, detecting, and treating disease.
  • UK Biobankflagship data/biobank partnerStrategic or Co-development PartnerThe UK Biobank Research Analysis Platform (RAP), enabled by DNAnexus, exponentially increases the scale and accessibility of the world's largest and most comprehensive biomedical database for researchers around the world to advance understanding of human disease. UK Biobank contains in-depth genetic and health information from 500,000 UK participants.
  • Ovationcore data partnerStrategic or Co-development PartnerOvation is a clinicogenomic data company committed to unlocking the potential of human genomic data to accelerate precision medicine. DNAnexus and Ovation teamed up to unlock large-scale precision health datasets to accelerate drug discovery.
  • TMA Precision Healthcore data partnerStrategic or Co-development PartnerTMA Precision Health and DNAnexus have partnered to advance basic and translational research for patients who have a rare disease. Qualified researchers can use the DNAnexus Precision Health Data Cloud to access and explore TMA's high-quality whole genome sequencing data and associated longitudinal medical records.
  • PacBiocore instrument partnerOEM/ Whitelabel/ Licensing PartnerPacBio is a premier life science technology company designing, developing, and manufacturing advanced sequencing solutions. DNAnexus and PacBio have collaborated to accelerate PacBio workflows on DNAnexus with Sentieon, with joint webinar content.
  • Element Biosciencescore instrument partnerOEM/ Whitelabel/ Licensing PartnerElement Biosciences is developing disruptive DNA sequencing and other omics technology for research and diagnostic markets. DNAnexus and Element Biosciences have partnered to allow customers to stream data from Element's AVITI System directly to their DNAnexus account, combining unmatched AVITI sequencing performance with the DNAnexus multi-omic analysis platform.
  • EpiCyphercore technology partnerTechnology or IntegrationEpiCypher launched CUTANA Cloud, a powerful epigenomic data analysis platform powered by DNAnexus that accelerates data analysis for leading chromatin mapping technologies including CUT&RUN and CUT&Tag. The platform was announced in November 2025.
  • BigOmicscore technology partnerTechnology or IntegrationDNAnexus and BigOmics partner to provide seamless omics analysis through a joint solution brief for biotech and pharma customers.
  • Boehringer Ingelheimflagship strategic partnerStrategic or Co-development PartnerBoehringer Ingelheim and DNAnexus are 2025 Prix Galien USA finalists for Best Digital Health Solution. Vada Perkins, VP & Global Head of Regulatory Intelligence & Policy at Boehringer Ingelheim, collaborates with DNAnexus on Trusted Regulatory Spaces and Cloud Transformation webinars.
  • Accelerated Cure Project for MSstrategic partnerStrategic or Co-development PartnerAccelerated Cure Project for MS (ACP) launched the ACP Data Challenge Pilot, a new initiative inviting researchers to interrogate ACP's longitudinal and multi-omic MS data in a single secure DNAnexus-powered environment (announced June 2026).
  • Longitude Prize on ALSstrategic partnerStrategic or Co-development PartnerLongitude Prize on ALS Discovery Award selections include 20 multidisciplinary teams using cutting-edge AI on DNAnexus-powered Prize datasets. Discovery Awardees were awarded £100,000 each plus access to the Prize datasets and a technical support package to drive computational work.
  • ARPA-Hflagship strategic partnerStrategic or Co-development PartnerARPA-H pioneers adaptive cancer treatment, leveraging DNAnexus technology. Featured as one of the trusted biomedical leaders on the DNAnexus homepage.

Scale indicators12 records

Recent moves6 records

Expansion highlights7 records

DNAnexus competitors and assessment

Company assessment

Broad incumbents

  • AWS HealthOmics: AWS HealthOmics provides managed genomics and multiomics storage and workflow services natively on AWS — the same cloud DNAnexus runs on — and represents both a partner and a potential disintermediator for less-regulated workloads.
  • Illumina Connected Analytics: Illumina, the dominant sequencing instrument vendor, offers Connected Analytics and DRAGEN-based cloud pipelines that overlap DNAnexus's NGS secondary analysis and multiomics workflows as part of a broader sequencing ecosystem.
  • Microsoft Azure Health Data Services: Microsoft Azure Health Data Services offers cloud-based healthcare and life sciences data services natively on Azure, competing and partnering with DNAnexus across pharma R&D and clinical genomics workloads.
  • Databricks (Healthcare & Life Sciences): Databricks' Healthcare & Life Sciences Lakehouse competes with DNAnexus for pharma R&D data unification, ML on multiomics, and collaborative analysis — at a broader, less biomedical-specialized level.

Emerging players

  • Owkin: Owkin applies federated AI to clinical and omics data for biopharma and academic medical centers, intersecting DNAnexus's territory in AI-enabled translational research and multimodal data collaboration.
  • Form Bio (subsidiary of DNA Script): Form Bio provides a cloud-based computational platform for genomics and synthetic biology data, with partial overlap to DNAnexus in NGS pipelines, multiomics analysis, and pharma R&D tooling.

Direct peers

  • BC Platforms: BC Platforms provides a genomics and real-world data platform used by biobanks, pharma, and healthcare systems, with a comparable Trusted Research Environment and B2B data monetization model.
  • Lifebit: Lifebit builds a cloud-based biomedical data platform (Lifebit CloudOS) for federated genomics and multi-omics analysis, directly competing with DNAnexus Precision Health Data Cloud for pharma, biobank, and translational research customers.
  • Velsera (formerly Seven Bridges Genomics): Velsera operates the Seven Bridges Platform for biomedical data analysis and clinical interpretation, overlapping DNAnexus in NGS analysis, multiomics workflows, and pharma/biopharma translational research customers.
  • SOPHiA GENETICS: SOPHiA GENETICS offers the SOPHiA DDM Platform for genomics data analysis and clinical decision support, competing directly in clinical diagnostics, NGS interpretation, and hospital lab workflows.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat6 records

Key risks6 records

Key highlights7 records

Customer concentration

DNAnexus social profiles

Digital presence

DNAnexus compliance and trust

Trust signal

Compliance9 records

DNAnexus financial estimates

Financial estimate

Revenue estimate

Valuation estimate

DNAnexus leadership team

Management profile

Number of profiles

Profiles14 records

DNAnexus funding detail

Funding detail

Funding overview

Funding rounds9 records

Investors18 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

DNAnexus M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about DNAnexus

What does DNAnexus do?

DNAnexus develops and operates the Precision Health Data Cloud, a SaaS platform hosted on AWS and Microsoft Azure that lets pharmaceutical, biotech, clinical diagnostics, biobank, and academic medical center customers store, analyze, and collaborate on multimodal omics and clinical data. The platform bundles bioinformatics pipelines, AI/ML tooling, a population-scale cohort browser, embedded JupyterLab with Spark, and compliance certifications (GxP, FedRAMP, HIPAA, GDPR, ISO 27001, CAP/CLIA), with attached Professional Services and Managed Services for implementation, GxP readiness, and ongoing operations.

Is DNAnexus a public or private company?

DNAnexus is a private company. It is classified as venture growth investor backed and is currently operating.

When was DNAnexus founded?

DNAnexus was founded in 2009. It employs 251 to 500 people.

Where is DNAnexus based?

DNAnexus is headquartered in Mountain View, United States, in the North America region.

How does DNAnexus make money?

Five revenue lines are on record. Platform Subscription (Precision Health Data Cloud SaaS) is the primary driver. The others are professional Services, managed Services, usage-Based Cloud Compute & Storage and data Enablement / B2B Data Sharing.

Who are DNAnexus's main competitors?

Broad incumbents on record are AWS HealthOmics, Illumina Connected Analytics, Microsoft Azure Health Data Services and Databricks (Healthcare & Life Sciences). Emerging players are Owkin and Form Bio (subsidiary of DNA Script). Direct peers are BC Platforms, Lifebit, Velsera (formerly Seven Bridges Genomics) and SOPHiA GENETICS.

Does DNAnexus have an API?

Yes. DNAnexus offers robust enterprise-grade APIs for programmatic access to platform capabilities including file and metadata management, spark cluster support, pipeline execution, and integration with bioinformatics workflows. The platform supports Docker-based custom tools as well as Nextflow and WDL workflow languages. Developers can build and automate analyses via the DNAnexus developer portal and API documentation. Developer documentation is at documentation.dnanexus.com.

What industry is DNAnexus in?

DNAnexus's product category is Cloud-based biomedical data analytics platform (Precision Health Data Cloud). Its primary akta.pro industry code is HLAGANAI, Bioinformatics, Multi-Omics Data Analysis & Interpretation Services, with a secondary code of HLAGAJAD, Bioinformatics & Multi-omics Analysis Software. Its NAICS code is 54151 and its SIC code is 7370.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
Business Wire BlogAdvances in AI Capabilities Solidifies DNAnexus as the Global Standard for Omics IntelligenceDNAnexus unveiled a new brand identity, evolving from processing omics results to omics intelligence. The company reports omics data compounding 38% annually and cites partnerships with organizations like Sanofi, Moderna, and the FDA. It aims to transform omics data into faster discoveries and better outcomes.Business Wire BlogCariGenetics Partners with DNAnexus to Launch First Caribbean Collaborative Genomics Research Infrastructure with NVIDIACariGenetics launched the Caribbean's first Trusted Research Environment with DNAnexus and NVIDIA to secure genomic data management and analysis. The platform houses consented data from over 2,000 individuals and uses NVIDIA Parabricks for variant calling. It aims to build regional genomics capacity and support future collaborative research.Tracxn2026 Funding Rounds & List of InvestorsDNAnexus has raised multiple funding rounds from 2009 to 2022, including Series A through Series H and conventional debt. The rounds range from $3.27 million to $3.84 million, with lead investors including Google Ventures and Foresite Capital.Business Wire BlogDNAnexus Named to the 2026 Inc. 5000 List, the Most Prestigious Ranking of America’s Fastest-Growing Private CompaniesDNAnexus was named to the 2026 Inc. 5000 list, recognizing its rapid growth among America's private companies. The company has achieved notable expansion in the health and life sciences sector, supporting a large global research community and advancing AI and omics data technology.FinancialContent Business PageDNAnexus Named to the 2026 Inc. 5000 List, the Most Prestigious Ranking of America’s Fastest-Growing Private CompaniesDNAnexus has been named to the 2026 Inc. 5000 list, recognizing it as one of America’s fastest-growing private companies based on three-year revenue growth from 2022 to 2025. The platform serves over 64,000 researchers and more than 130 enterprise customers in the healthcare and life sciences sectors. This recognition highlights DNAnexus's role in processing over 135 petabytes of omics data for scientific discovery.FortunebusinessinsightsTop 10 Genomic Data Platform Companies 2026Fortune Business Insights published a listicle profiling the top 10 genomic data platform companies, noting the industry is expected to grow at a CAGR of 17.14% to reach USD 20.01 billion by 2034. The article profiles each company with recent activities including product launches, collaborations, and acquisitions such as QIAGEN's acquisition of Genoox in May 2025 and DNAnexus's collaboration with Oracle Health in September 2025. The piece also includes a forward-looking section discussing how AI, quantum computing, and privacy-enhancing technologies are expected to reshape genomic data platform adoption in healthcare.Business Wire BlogDNAnexus Wins MedTech Breakthrough’s PharmaTech Innovation AwardDNAnexus, an enterprise orchestration platform for precision health, received the PharmaTech Innovation Award from the MedTech Breakthrough Awards program, which reviewed over 5,000 nominations to recognize excellence in digital health and medical technology. The award recognizes DNAnexus's AI-enabled platform for its ability to transform multimodal omics data into scalable workflows that help pharma organizations identify novel targets, validate biomarkers, and optimize clinical trial designs within a regulatory-ready framework. DNAnexus stated the recognition reflects its commitment to empowering biopharma partners to accelerate the delivery of targeted therapeutics.openPR.comSegmentation, Major Trends, and Competitive Overview of the Life Sciences Information Technology (IT) MarketThe global life sciences information technology market is projected to reach $56.16 billion by 2030, growing at a compound annual growth rate of 14.0%, driven by increasing adoption of cloud-native solutions, AI-powered bioinformatics tools, and interoperable platforms for healthcare data exchange. In January 2024, DNAnexus Inc. partnered with Poland-based Intelliseq to integrate automated genomic variant interpretation into its precision health data cloud platform, exemplifying the strategic collaborations driving innovation in the sector. Additionally, Terumo BCT Inc. received FDA approval in February 2023 for its IMUGARD WB Platelet Pooling Set, extending platelet shelf life to seven days and supporting growing clinical demands in blood therapies.HpcwireSince 1987 – Covering the Fastest Computers in the World and the People Who Run ThemThe article describes how AI is driving a structural shift in scientific research toward "experimental data lakes" that capture raw data directly from research workflows along with experimental context, replacing traditional one-and-done data storage approaches. Companies including Benchling, Dotmatics, DNAnexus, and Schrödinger are building platforms in this space to make scientific data reusable and accessible. The article suggests this trend is moving science toward more autonomous experimentation, with data becoming core infrastructure for modern scientific discovery.